These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12576315)

  • 1. Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia.
    Branger J; van den Blink B; Weijer S; Gupta A; van Deventer SJ; Hack CE; Peppelenbosch MP; van der Poll T
    Blood; 2003 Jun; 101(11):4446-8. PubMed ID: 12576315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia.
    Branger J; van den Blink B; Weijer S; Madwed J; Bos CL; Gupta A; Yong CL; Polmar SH; Olszyna DP; Hack CE; van Deventer SJ; Peppelenbosch MP; van der Poll T
    J Immunol; 2002 Apr; 168(8):4070-7. PubMed ID: 11937566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colistin dampens fibrinolysis and endothelial activation during endotoxaemia. A randomised, double blind trial.
    Schoergenhofer C; Matzneller P; Mußbacher M; Schmid JA; Jilma-Stohlawetz P; Zeitlinger M; Jilma B
    Thromb Haemost; 2017 Aug; 117(9):1714-1721. PubMed ID: 28796276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia.
    Schoergenhofer C; Schwameis M; Gelbenegger G; Buchtele N; Thaler B; Mussbacher M; Schabbauer G; Wojta J; Jilma-Stohlawetz P; Jilma B
    Thromb Haemost; 2018 Jul; 118(7):1176-1184. PubMed ID: 29864779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia.
    de Kruif MD; Lemaire LC; Giebelen IA; van Zoelen MA; Pater JM; van den Pangaart PS; Groot AP; de Vos AF; Elliott PJ; Meijers JC; Levi M; van der Poll T
    J Immunol; 2007 Feb; 178(3):1845-51. PubMed ID: 17237435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia.
    Pajkrt D; van der Poll T; Levi M; Cutler DL; Affrime MB; van den Ende A; ten Cate JW; van Deventer SJ
    Blood; 1997 Apr; 89(8):2701-5. PubMed ID: 9108387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteers.
    Schoergenhofer C; Buchtele N; Gelbenegger G; Derhaschnig U; Firbas C; Kovacevic KD; Schwameis M; Wohlfarth P; Rabitsch W; Jilma B
    Sci Rep; 2019 Jul; 9(1):11136. PubMed ID: 31366975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans.
    van der Poll T; Coyle SM; Levi M; Jansen PM; Dentener M; Barbosa K; Buurman WA; Hack CE; ten Cate JW; Agosti JM; Lowry SF
    Blood; 1997 May; 89(10):3727-34. PubMed ID: 9160678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epinephrine exerts anticoagulant effects during human endotoxemia.
    van der Poll T; Levi M; Dentener M; Jansen PM; Coyle SM; Braxton CC; Buurman WA; Hack CE; ten Cate JW; Lowry SF
    J Exp Med; 1997 Mar; 185(6):1143-8. PubMed ID: 9091588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
    Pajkrt D; Lerch PG; van der Poll T; Levi M; Illi M; Doran JE; Arnet B; van den Ende A; ten Cate JW; van Deventer SJ
    Thromb Haemost; 1997 Feb; 77(2):303-7. PubMed ID: 9157586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.
    de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van Der Poll T
    Blood; 2000 Feb; 95(4):1124-9. PubMed ID: 10666180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia.
    Renckens R; Weijer S; de Vos AF; Pater JM; Meijers JC; Hack CE; Levi M; van der Poll T
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):483-8. PubMed ID: 14739127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans.
    Verbon A; Meijers JC; Spek CA; Hack CE; Pribble JP; Turner T; Dekkers PE; Axtelle T; Levi M; van Deventer SJ; Reitsma PH; van der Poll T
    J Infect Dis; 2003 Jan; 187(1):55-61. PubMed ID: 12508146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapulmonary administration of a p38 mitogen activated protein kinase inhibitor partially prevents pulmonary inflammation.
    Hoogendijk AJ; Pinhanços SS; van der Poll T; Wieland CW
    Immunobiology; 2013 Apr; 218(4):435-42. PubMed ID: 22727776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of p38 MAPK in ICAM-1 expression of vascular endothelial cells induced by lipopolysaccharide.
    Yan W; Zhao K; Jiang Y; Huang Q; Wang J; Kan W; Wang S
    Shock; 2002 May; 17(5):433-8. PubMed ID: 12022767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of p38 MAPK in LPS induced ICAM-1 expression on endothelial cell].
    Yan W; Jiang Y; Huang Q
    Zhonghua Shao Shang Za Zhi; 2001 Feb; 17(1):32-5. PubMed ID: 11876908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence against an effect of endothelin-1 on blood coagulation, fibrinolysis, and endothelial cell integrity in healthy men.
    Kapiotis S; Jilma B; Szalay T; Dirnberger E; Wagner O; Eichler HG; Speiser W
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2861-7. PubMed ID: 9409267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibitor of p38 mitogen-activated protein kinase inhibits lipopolysaccharide-induced interleukin-8 expression in human pulmonary vascular endothelial cells.
    Hashimoto S; Gon Y; Matsumoto K; Maruoka S; Takeshita I; Hayashi S; Asai Y; Jibiki I; Machino T; Horie T
    J Pharmacol Exp Ther; 2000 May; 293(2):370-5. PubMed ID: 10773004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia.
    Derhaschnig U; Reiter R; Knöbl P; Baumgartner M; Keen P; Jilma B
    Blood; 2003 Sep; 102(6):2093-8. PubMed ID: 12750166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.